Presentation Beckman Coulter with Notes (from

New Post Public Reply Private Reply Replies (1) Message Board
Sunny3999
2,462
Presentation Beckman Coulter with Notes (from Yahoo-Board):

Dr. Bruce Patterson thanks Beckman Coulter for the invitation.
20200522172851-img-5932.jpg
He wants to talk about Rantes/CCL5.
These are levels we've never seen before in Covid patients.
How do these immune cells get to sites of inflammation?
Rantes is an "immune magnet."
20200522172907-img-5933.jpg
We have looked at a set of very critical patients at Albert Einstein.
You see a very complex disease.
Rantes seems to be acting as the quarterback to bring cells to where they are needed.
But it brings them to such an extent that you get sequestration in lungs, liver, etc. The cytokyne storm is triggered.
20200522172942-img-5934.jpg
Macrophages and NK cells and lymphocytes come in and bring in new cells.
See in mild to moderate patients but this immune disruption/chaos doesn't start for a while.
It is tipped from the expression of Rantes.
It is well described in slide - initial virologic phase/sometimes asymptomatic - then uncontrolled response which leads to immune chaos/immune suppression and more cytokines.
20200522173034-img-5935.png
We were always trying to find a way to control.
Leron blocks binding of CCL5/Rantes and controls all the effects of Rantes.
We also found the immune disruption.
20200522173117-img-5936.png
Severely decreased CV4-CV8 cells also present.
We've been luck that we have tools to measure all the manifestations of Covid.
[Brags on his hardware]
20200522173207-img-5937.png
One of the discrepancies in the world is that no one knows why these drugs are working.
We have developed a suite of diagnostics that show what is happening.- i.e. increasing cells, decreasing IL6, decreasing viral lode.
This is the panel we've been using: i.e. T-Cell exhaustion.
We see dramatic decreases in IL6 in patients across the country
We are able to do cytokine panels right on the cytoplex.
20200522173240-img-5939.png
We can do profiling all on the same machine with three different assays.
In Covid patients, Rantes is increased to 3x to 5x quickly and that's the trigger from a viral disease to an immune disease.
That is borne out.
Platelets go up and are activated.
You can see why there may be issues with Thrombosis and coagulation.
C-reactive protein is high and it is brought down significant in patients on Leron.
Liver enzymes come down on Leron.
Recurring theme. The body is on fire in Covid. When you put out that fire, the viral load goes down which is remarkable.
These are all the key parameters. A lot of people talk about targeting various items i.e. IL6.
The diff with CCL5 is that it is initiating this storm.
The beauty is that Leron blocks CCL5 and brings down IL6.
The amazing thing about Rantes is that it crashes at day 14.
In some of the very severe patients, it comes down at day 21.
It determines two things 1) when do you initiate and 2) when do you stop.
The most astonishing finding in study under peer review: we were first to find and quantify viral load using droplet ...ICR. It is perfect technology.
We did find it in every single patient.
20200522173308-img-5940.png
Plasma viral load came down in these patients on Leron even though it is an immune modulator.
It essentially restores the immune system.
And quiets the cytokine storm.
All viral loads went down to undetectable at day 14.
Some things are not in paper.
20200522173356-img-5941.png
We saw decreases in immune exhaustion and markers.
Patients with renal failure had higher exhaustion.
The data has already been submitted for Leron in HIV.
Initially, when we advanced the theory that Leron might be effective in Covid, there was criticism, but we found the Rantes issue.
What we are finding in Covid immunologically also impacts the research in cancer and HIV.
All needs far more invest.
But these are exciting mechanisms previously undescribed.
In summary Covid, is biphasic heterogenous in 4 stages.
Very different distinctions in these phases.
Rantes signals the transition from virologic to immunologic disease.
Some patients were on life support and came off life support and are now home and at rehab facilities.
20200522173422-img-5942.png
It is anectodal, but my response is anectdotes don't come off life support.
We know what we have to do to prove to the community at large, but with 25 years experience, you know when something is working.
The effect is dramatic in moderate and severe.
The double blind studies are underway.
To date, there has been a disconnect between mechanism and outcome.
We see that in several other agents.
20200522173447-img-5943.png
There are a number of hurdles for other drugs that can't be used.
By looking at immunology of covid, we've learned a lot about this drug.
It is exciting to see something work like this beyond simply blocking a cytokine receptor.

Now questions:
Any competitors that have drugs that do same?
A: there are, like ___, which make CCL5 inhibitors. But, Leron is very close to submitting its trials to the FDA and we have a body of data that aligns the mechanism of operation with outcome. If we can remove the specter of death and intubation, we can get back to normal.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Manulife's $750M US Offering: Risky or Strategic?

Updated Category News Views 2

Manulife: Debuting $750M in Subordinated Notes When it comes to Manulife's latest move, it's all about the numbers. They've priced a U.S. public offering of a meaty $750 million in subordinated notes at an enticing 6.146% interest rate. That's no pocket change, folks, and it highlights a strategy or a gamble, depending on your view. But here's the kicker: these notes may...

Continue Reading
Palmer's Design Fuels Child Cancer Awareness Drive

Updated Category News Views 6

Imagine a cancer struggle fueling creativity – a hopeful story from the racetrack lights up this reality as Valvoline and a young survivor rev up their engines for children with blood cancer. Powerful Partnership Takes Unforgettable Turn Palmer Goforth, a twelve-year-old cancer survivor, never imagined his hobby of drawing sketches would lead to designing a NASCAR car....

Continue Reading
D-Orbit Banks on GomSpace for 2026 Space Ventures

Updated Category News Views 4

Pioneering Paths in Space Logistics Nobody ever said that conquering the final frontier was going to be easy. But D-Orbit, the trailblazer in space logistics, is inking deals like they're playing a cosmic chess game, and GomSpace is the knight they’re moving across the board. Their latest maneuver? GomSpace gets tasked with powering the D-Orbit's missions through 2027,...

Continue Reading
Cogent Communications Faces Investor Legal Battle

Updated Category News Views 1

Bumps on the Cogent Communications Road Things always look clear in hindsight, and for Cogent Communications Holdings (NASDAQ: CCOI), that rearview might be filled with red flags they've ignored too long. Here we are, a securities fraud class action hanging over their heads because they couldn't keep clean financial house. The Numbers Don't Lie Cogent's Q2 2026 numbers...

Continue Reading
American Tungsten's Bold Play in Nevada is Noteworthy

Updated Category News Views 2

American Tungsten's Shifting Focus Today we're chewing over some intriguing moves from American Tungsten & Antimony, Ltd. (ASX: AT4; OTCQX: ATALF). These cats are eyeing a chunk of the strategic metals market. They've engaged Metso Finland Oy to whip up a Scoping Study for an ammonium paratungstate (APT) production circuit at their Del Sol Refinery in Nevada. Why Tungsten...

Continue Reading
Space Collaboration Inches Forward with Extended Talks

Updated Category News Views 1

It seems like every time you blink, the folks over at Maritime Launch Services and Isar Aerospace are at it again. This time, they've decided to extend the deadline for their statement of work by a couple of weeks—now shooting for mid-September 2026. You could say they're taking their time, but really, sometimes that's what you've gotta do when you're trying to launch...

Continue Reading
Clean Energy's Paradox: Speed vs. Emission Cuts

Updated Category News Views 3

Tackling the Two-Speed Transition It's like this: clean energy's racing ahead but dragging a stubborn mule behind. Sure, we saw solar and EVs hustle past every forecast last year, with a record-breaking $2.1 trillion in investment. But, ever notice how despite all this, emissions aren't exactly nose-diving? Global CO2's hovering like a bad cold, thanks to the unending...

Continue Reading
Hot Spell Hits Carolinas: Energy Costs Heat Up

Updated Category News Views 2

Sweltering Heat Brings Energy Challenges The Carolinas are in for a sizzling start to September, with forecasts showing temperatures hitting the mid-to-upper 90s. It's the kind of heat that doesn't just make you sweat; it sends energy bills skyrocketing. Why? Because air conditioners need to work overtime just to keep indoor temps from climbing. You crank your AC, and...

Continue Reading
M Social's NYC Edition Merges Sport and Community

Updated Category News Views 4

A Bold Move in the Heart of Manhattan You know when a hotel chains itself to a major event like the US Open, it's looking to make a statement—bold, loud, and clear. M Social Hotel New York Times Square did just that, turning its space into a powerhouse hub of sport, culture, and community right in Times Square. Over two days, they brought together some of the top ATP...

Continue Reading
PCOS/PMOS Symposium 2026: A Game-Changer for Health

Updated Category News Views 3

A Fiery Gathering for Future PCOS/PMOS Progress Kicking off in Boston on September 19, the PCOS/PMOS Awareness Symposium 2026 isn't your typical chalk-and-talk affair. This gathering is a powerhouse meld of patients, experts, and the policy world all under one roof. You think that's easy to pull off? Not a chance. It's cemented by the PCOS Challenge group and Brigham's...

Continue Reading

Top 5 Most Recently Viewed Articles

KPN's €250 Million Share Buyback Strategy: A Detailed Review

Updated Category News Views 105

KPN's Share Buyback Progress KPN has taken significant steps in its endeavor to return capital to shareholders by repurchasing a substantial number of its ordinary shares. In a recent report covering the period between 30 June and 4 July, KPN announced the repurchase of 1,655,000 shares at an average price of €4.11 each, amounting to a total expenditure of €6.8...

Continue Reading
Ivy Bank Achieves Major Milestone with Over $1 Billion in Deposits

Updated Category News Views 134

Ivy Bank Achieves Major Milestone with Over $1 Billion in Deposits BOSTON-- Cambridge Savings Bank (CSB), known for its customer-first approach and extensive banking services, has announced that its digital banking division, Ivy Bank, has surpassed a remarkable milestone of $1 billion in deposits. This achievement comes as Ivy Bank continues to expand its reach across the...

Continue Reading
Octopus AIM VCT Announces Equity Issuance and Voting Rights Update

Updated Category News Views 241

Octopus AIM VCT plc Issues New Ordinary Shares Octopus AIM VCT plc, a prominent entity in the investment sector, is excited to share significant updates regarding its equity positioning. In a recent announcement, the company confirmed the issuance of 8,893,138 Ordinary Shares of 1p each, a move aimed to enhance its capital base and support its ongoing strategic...

Continue Reading
HONGQI Celebrates Award for Sustainable Innovation in Germany

Updated Category News Views 189

HONGQI Honored for Environmental Excellence HONGQI has recently earned recognition for its strong dedication to environmental sustainability by winning the Best Case for International Cooperation Award at a significant conference. This gathering aimed to encourage sustainable growth and share best practices in the corporate sector, providing a platform for businesses to...

Continue Reading
Advance Partners Welcomes Kendra Cato as New Director

Updated Category News Views 365

Advance Partners Strengthens Leadership with New Appointment Advance Partners, a leading provider of payroll funding and back-office solutions, has made a significant leadership change by appointing Kendra Cato as the new Director of Strategic Partnerships. This strategic hire aims to enhance relationships within the staffing industry and provide clearer direction for...

Continue Reading